Multidisciplinary Therapy and Molecular Testing in Early-Stage NSCLC

Dr Melissa Johnson and Dr Myung-Ju Ahn emphasize the importance of a multidisciplinary approach to treatment and biomarker testing for patients with early-stage NSCLC.

Related Videos
View All
Related Content